Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users

Journal of Substance Abuse

Volumn 13, Issue 1-2, 2001, Pages 155-167

  Metsch, Lisa R ^a,b   Pereyra, Margaret ^a   Brewer, Toye H ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Care; Crack; Drug users; HIV positive

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HEALTH CARE; HEALTH INSURANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; SMOKING; STATISTICAL MODEL; ADDICTION; COCAINE DEPENDENCE; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; SUBSTANCE ABUSE; UNITED STATES;

COCAINE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COCAINE-RELATED DISORDERS; CRACK COCAINE; FEMALE; FLORIDA; HIV INFECTIONS; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 0035238414     PISSN: 08993289     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-3289(01)00064-5     Document Type: Article

References (39)

1. Bernstein E., Bernstein J., Levenson S. Project ASSERT: an ED-based intervention to increase access to primary care, preventive services, and the substance abuse treatment system. Annals of Emergency Medicine. 30:1997;181-189.
2. Bozzette S., Berry S., Duan N., Frankel M., Leibowitz A., Lefkowitz D., Emmons C., Senterfitt J., Berk M., Morton S., Shapiro M. The care of HIV-infected adults in the United States. New England Journal of Medicine. 339:1998;1897-1904.
3. Carrieri M., Moatti J., Vlahov D., Obadia Y., Reynaud-Maurupt C., Chesney M. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. Journal of Epidemiology and Community Health. 53:1999;4-8.
4. Diagnosis and reporting of HIV and AIDS in states with integrated HIV and AIDS surveillance - United States, January 1994-June 1997. MMWR. 47:1998;309-314.
5. Celentano D., Vlahov D., Cohn S., Shadle V., Obasanjo O., Moore R. Self-reported antiretroviral therapy in injection drug users. JAMA, Journal of the American Medical Association. 280:1998;544-546.
6. Chen K., Scheier L., Kandel D. Effects of chronic cocaine use on physical health: a prospective study in a general population sample. Drug and Alcohol Dependence. 43:1996;23-37.
7. Chitwood D., McBride D., Metsch L., Comerford M., McCoy C. A comparison of the need for health care and use of health care by injection-drug users, other chronic drug users, and nondrug users. American Behavioral Scientist. 41:1998;1107-1122.
8. Cornish J., O'Brien C. Crack cocaine abuse: an epidemic with many public health consequences. Annual Review of Public Health. 17:1996;259-273.
9. Cousineau M. Health status of and access to health services by residents of urban encampments in Los Angeles. Journal of Health Care for the Poor and Underserved. 8:1997;70-82.
10. Crystal S. Health-care barriers and utilization patterns among intravenous drug users with HIVdisease. AIDS and Public Policy Journal. 7:1992;187-198.
11. Cunningham W., Hays R., Williams K., Beck K., Dixon W., Shapiro M. Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Medical Care. 33:1995;739-754.
12. Cunningham W., Mosen D., Hays R., Andersen R., Shapiro M. Access to community-based medical services and number of hospitalizations among patients with HIV disease: are they related? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 13:1996;327-335.
13. Dorrucci M., Pezzotti P., Phillips A., Alliegro M., Rezza G. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study Group. AIDS. 11:1997;461-467.
14. Farabee D., Leukefeld C., Hays L. Accessing drug-abuse treatment: perceptions of out-of-treatment injectors. Journal of Drug Issues. 28:1998;381-394.
15. Kral A., Blumenthal R., Booth R., Watters J. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. American Journal of Public Health. 88:1998;108-113.
16. Martin J., Smith B., Mathews T., Ventura S. Births and deaths: preliminary data for 1998. National Vital Statistics Report. 47:1999;1-45.
17. McBride D., Mutch P., Kicher C., Inciardi J., McCoy H., Pottieger A. Barriers to treatment among crack-dependent and other drug-abusing inner-city women. Chitwood D., Inciardi J., Rivers J. The American pipe dream: crack cocaine and the inner city. 1996;115-128 Hartcourt Brace College, Fort Worth, TX.
18. McCoy C., Metsch L., Anwyl R. Dual epidemics: crack cocaine and HIV/AIDS. Chitwood D., Inciardi J., Rivers J. The American pipe dream: crack cocaine and the inner city. 1996;89-103 Hartcourt Brace College Publishers, Fort Worth, TX.
19. Mor V., Fleishman J., Dresser M., Piette J. Variation in health service use among HIV-infected patients. Medical Care. 30:1992;17-29.
20. Morrison A., Elliott L., Gruer L. Injecting-related harm and treatment-seeking behaviour among injecting drug users. Addiction. 92:1997;1349-1352.
21. Mostashari F., Riley E., Selwyn P., Altice F. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 18:1998;341-348.
22. Padgett D., Struening E. Influence of substance abuse and mental disorders on emergency room use by homeless adults. Hospital and Community Psychiatry. 42:1991;834-838.
23. Palella F. Jr., Delaney K., Moorman A., Loveless M., Fuhrer J., Satten G., Aschman D., Holmberg S. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine. 338:1998;853-860.
24. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation MMWR. 47:1998;42-82.
25. Samet J., Freedberg K., Stein M., Lewis R., Savetsky J., Sullivan L., Levenson S., Hingson R. Trillion virion delay: time from testing positive for HIV to presentation for primary care. Archives of Internal Medicine. 158:1998;734-740.
26. Schwartz B., Dilley J., Sorensen J. Case management of substance abusers with HIV disease. Journal of Case Management. 3:1994;173-178.
27. Seage G., Herta T., Stone V., Epstein A. The effects of intravenous drug use and gender on the cost of hospitalization for patients with AIDS. Journal of Acquired Immune Deficiency Syndromes. 6:1993;831-839.
28. Selwyn P., Budner N., Wasserman W., Arno P. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Report. 108:1993;492-500.
29. Shapiro M., Morton S., McCaffrey D., Senterfitt J., Fleishman J., Perlman J., Athey L., Keesey J., Goldman D., Berry S., Bozzette S. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA, Journal of the American Medical Association. 281:1999;2305-2315.
30. Sherer R. Adherence and antiretroviral therapy in injection drug users. editorial; comment JAMA, Journal of the American Medical Association. 280:1998;567-568.
31. Siegal H., Carlson R., Falck R., Wang J. Drug abuse treatment experience and HIV risk behaviors among active drug injectors in Ohio. American Journal of Public Health. 85:1995;105-108.
32. Siegel K., Karus D., Raveis V. Testing and treatment behaviour of HIV-infected women: white, African-American, Puerto Rican comparisons. AIDS Care. 9:1997;297-309.
33. Solomon L., Frank R., Vlahov D., Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal of Public Health. 81:1991;1285-1290.
34. Solomon L., Frank R., Vlahov D., Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal of Public Health. 81:1991;1285-1290.
35. Solomon L., Stein M., Flynn C., Schuman P., Schoenbaum E., Moore J., Holmberg S., Graham N. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17:1998;253-261.
36. Stein M., Urdaneta M., Clarke L., Maksad J., Sobota M., Hanna L., Marks L.E. Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance. Journal of Addictive Disorders. 19:2000;85-94.
37. Strathdee S., Palepu A., Cornelisse P., Yip B., O'Shaughnessy M., Montaner J., Schechter M., Hogg R. Barriers to use of free antiretroviral therapy in injection drug users. JAMA, Journal of the American Medical Association. 280:1998;547-549.
38. Valdiserri R., Holtgrave D., West G. Promoting early HIV diagnosis and entry into care. AIDS. 13:1999;2317-2330.
39. Weissman G., Melchior L., Huba G., Smereck G., Needle R., McCarthy S., Jones A., Genser S., Cottler L., Booth R. Women living with drug abuse and HIV disease: drug abuse treatment access and secondary prevention issues. Journal of Psychoactive Drugs. 27:1995;401-411.